NeuroPace (NPCE) EBIT Margin (2020 - 2026)

NeuroPace (NPCE) recorded quarterly EBIT Margin of 25.23% in Q1 2026, down 279.65% quarter-over-quarter from 6.65% in Q4 2025, and down 238.0% on a YoY basis from 18.28% in Q1 2025.

NeuroPace (NPCE) EBIT Margin (2020 - 2026) Analysis & Trends

NeuroPace's EBIT Margin history runs 7 years deep, the most recent figure standing at 25.23% for Q1 2026.

  • In Q1 2026, EBIT Margin fell 238.0% year-over-year to 25.23%; the TTM figure through Mar 2026 stood at 16.84% (up 602.0% YoY), while the FY2025 annual figure was 16.34%, up 1078.0% from the prior year.
  • EBIT Margin was 25.23% for Q1 2026 at NeuroPace, down from 6.65% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 6.65% in Q4 2025 to a low of 107.59% in Q2 2022.
  • Historically, EBIT Margin has averaged 43.27% across 5 years, with a median of 32.35% in 2024.
  • The sharpest annual moves came in 2022 and 2023: EBIT Margin plunged 7113 bps in 2022, then surged 6002 bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 77.09% in 2022, then soared by 64 bps to 28.04% in 2023, then soared by 39 bps to 17.02% in 2024, then surged by 61 bps to 6.65% in 2025, then plunged by 280 bps to 25.23% in 2026.
  • The last three EBIT Margin figures came in at 25.23% (Q1 2026), 6.65% (Q4 2025), and 9.51% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.05%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 15.55%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 16.24%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.17%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.04%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.94%
10 NeuroPace 527.50 Mn 473.52 Mn 18.05 Mn -25.23%

Historic Data

Download Data
DateValue
Mar 31, 2026 -25.23%
Dec 31, 2025 -6.65%
Sep 30, 2025 -9.51%
Jun 30, 2025 -29.01%
Mar 31, 2025 -22.85%
Dec 31, 2024 -17.02%
Sep 30, 2024 -20.15%
Jun 30, 2024 -32.35%
Mar 31, 2024 -41.63%
Dec 31, 2023 -28.04%
Sep 30, 2023 -36.22%
Jun 30, 2023 -47.57%
Mar 31, 2023 -57.48%
Dec 31, 2022 -77.09%
Sep 30, 2022 -91.41%
Jun 30, 2022 -107.59%
Mar 31, 2022 -85.83%
Dec 31, 2021 -81.98%
Sep 30, 2021 -60.38%
Jun 30, 2021 -36.46%